0000899243-22-003573.txt : 20220128 0000899243-22-003573.hdr.sgml : 20220128 20220128175357 ACCESSION NUMBER: 0000899243-22-003573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Hazel CENTRAL INDEX KEY: 0001698307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 22570493 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-26 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001698307 Hunt Hazel C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 Chief Scientific Officer Common Stock 2022-01-26 4 M 0 40000 3.32 A 78493 D Common Stock 2022-01-26 4 F 0 25350 17.16 D 53143 D Stock Option (Right to Buy) 3.32 2022-01-26 4 M 0 40000 0.00 D 2022-02-01 Common Stock 40000 0 D These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 1, 2022. Fully exercisable. /s/ Joseph Douglas Lyon, Attorney-in-Fact for Hazel Hunt 2022-01-28